[Hyperlipoproteinemia, the Apo-E genotype and bone density]

Area of Science:

• Endocrinology and Metabolism
• Bone Biology and Osteoporosis
• Cardiovascular Disease and Atherosclerosis

Context:

• Atherosclerosis and osteoporosis frequently coexist, particularly in older individuals, but are often considered distinct conditions.
• Emerging epidemiological data suggest potential links between these diseases, prompting investigation into shared underlying factors.
• Genetic, hormonal, and biochemical factors are being explored to explain the observed associations, with a focus on apolipoprotein E and lipid metabolism.

Purpose:

• To investigate the hypothesis that apolipoprotein E genotype, plasma lipid levels, and bone mineral density are interconnected.
• To examine the relationship between specific apolipoprotein E genotypes (E2/2 and E4/4 homozygotes) and bone health markers.
• To assess correlations between lipid profiles (cholesterol, triglycerides) and bone mineral density in postmenopausal women and apolipoprotein E homozygotes.

Summary:

• The study analyzed bone mineral density and lipid profiles in 18 apolipoprotein E2/2 and E4/4 homozygotes and 130 postmenopausal women.
• No significant differences in bone mineral density or bone turnover markers were found between apolipoprotein E2/2 and E4/4 homozygotes.
• A negative correlation was observed between lumbar spine bone mineral density and cholesterol and triglyceride concentrations in both study groups.

Impact:

• The findings do not support an association between apolipoprotein E genotype and bone mineral density or bone metabolism markers.
• The observed negative correlation between plasma lipids and bone mineral density suggests a potential detrimental effect of hyperlipidemia on bone metabolism.
• This research contributes to understanding the complex interplay between cardiovascular risk factors and skeletal health, particularly in aging populations.